QuantLogix ← MET scorecard
📅 MET Earnings Preview
MetLife, Inc.
Next report (est.)
October 15, 2026
Countdown
124 days
EPS growth YoY
+35.9%
Revenue growth YoY
+2.7%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
May 7, 2026 ±2.2% -1.7% over-priced
November 7, 2025 ±3.1% +0.2% over-priced
August 7, 2025 ±2.2% -2.8% under-priced
May 1, 2025 ±2.6% +0.5% over-priced
August 1, 2024 ±1.9% -1.4% over-priced
May 2, 2024 ±2.0% -2.3% under-priced
November 2, 2023 ±2.1% +0.1% over-priced
August 4, 2023 ±1.6% -1.4% over-priced
Across these reports, options implied an average ±2.2% move vs an actual average of 1.3% — the stock stayed inside the implied band 75% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q1 FY2026 $1.74 $19.1B $1.2B
Q4 FY2025 $1.17 $23.8B $816M
Q3 FY2025 $1.22 $17.4B $902M
Q2 FY2025 $1.03 $17.3B $735M
Live 5-factor engine read: Buy · 65/100 Full scorecard →
Get alerted before every MET report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on MET before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

MetLife, Inc. (MET) reports in 124 days, with the next report estimated for October 15, 2026. Across the last 8 reports, options priced an average ±2.2% earnings move while the stock actually moved 1.3% on average — the market has systematically over-priced MET's earnings risk. Fundamentals into the print: EPS up 35.9% year-over-year, revenue up 2.7%. QuantLogix's live 5-factor engine currently reads MET as a buy at 65/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →